caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679599450

Tai-Hung Mak

OphthalmologyAshtabula, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Tai-Hung Mak's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 22 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ASHTABULA COUNTY MEDICAL CENTER264822
UNIVERSITY HOSPITALS GENEVA MEDICAL CENTER4684
CHAGRIN SURGERY CENTER, LLC3857
Edward Wiese
Internal Medicine · Ashtabula, OH
37156
Thomas Jones
Diagnostic Radiology · Perrysburg, OH
3448
Michelle Hagan
Physician Assistant · Solon, OH
3250
Bhupendra Patel
Diagnostic Radiology · Cleveland, OH
3140
James Chillcott
Family Practice · N Kingsville, OH
31108
DSILVA, ORLANDO2044
Kimberly Fitzpatrick
Certified Registered Nurse Anesthetist (CRNA) · Ashtabula, OH
2030
CHAPEK, CLAUDIA1823
UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER1731
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
264
Beneficiaries
—
Total drug cost
$4K
Distinct drugs
4
Brand share
4.5%
Top prescribed drugs
Latanoprost207 claims
Brimonidine Tartrate33 claims
Dorzolamide Hcl/Timolol Maleat12 claims
Pilocarpine Hcl12 claims
QUALITY · MIPS · 2024
Final MIPS score
83.5
Quality
81.2
Cost
78.2
Improvement activities
40.0
Promoting interop.
83.0
Payment adjustment
0.36%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.